SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
EQ-5D in Central and Eastern Europe: 2000–2015
16 references·6 citing·27 second hop
EQ-5D in Central and Eastern Europe: 2000–2015 (2016)EQ-5D in Central and Eastern Europe: 2000…Can The EQ-5D Detect Meaningful Change? A Systematic Review (2015)Can The EQ-5D Detect Meaningf…Validity of EQ-5D-5L in stroke (2014)Validity of EQ-5D-5L in strokeThe minimum clinically important difference for EQ-5D index: a critical review (2014)The minimum clinically import…Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study (2012)Measurement properties of the…Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets (2012)Interim Scoring for the EQ-5D…Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) (2011)Development and preliminary t…Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study (2010)Feasibility, reliability, and…Development of the EQ-5D-Y: a child-friendly version of the EQ-5D (2010)Development of the EQ-5D-Y: a…A review of health utilities using the EQ-5D in studies of cardiovascular disease (2010)A review of health utilities …Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Preferred reporting items for…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for…Health Utilities Using the EQ-5D in Studies of Cancer (2007)Health Utilities Using the EQ…A single European currency for EQ-5D health states (2003)A single European currency fo…Guidelines for Pharmacoeconomic Studies (1997)Guidelines for Pharmacoeconom…EuroQol: the current state of play (1996)EuroQol: the current state of…EuroQol - a new facility for the measurement of health-related quality of life (1990)EuroQol - a new facility for …Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary (2020)Parallel Valuation of the EQ-…An EQ-5D-5L Value Set for Vietnam (2020)An EQ-5D-5L Value Set for Vie…Valuing Health State: An EQ-5D-5L Value Set for Ethiopians (2019)Valuing Health State: An EQ-5…Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe (2019)Valuation of EQ-5D-5L Health …Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease (2018)Validity of the EQ-5D-5L and …Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients (2017)Measurement properties of the…The New Zealand Medical Journal 1887-1987. (1987)EQ-SD: a measure of health status from the EuroQol Group (2001)Valuing health-related quality of life: An EQ-5D-5L value set for England (2017)Modeling Valuations for EuroQol Health States (1997)EQ-5D and the EuroQol Group: Past, Present and Future (2017)Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. (1968)The Measurement of Observer Agreement for Categorical Data (1977)The Strengths and Difficulties Questionnaire: A Research Note (1997)Valuation of the Child Health Utility 9D Index (2012)A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D (2018)Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries (2018)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015)Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling: Report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force (2013)The European KIDSCREEN approach to measure quality of life and well-being in children: development, current application, and future advances (2013)The estimation of a preference-based measure of health from the SF-36 (2002)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Dutch Tariff for the Five-Level Version of EQ-5D (2016)Psychometric properties of the EQ-5D-5L: a systematic review of the literature (2020)Correspondence between EQ-5D health state classifications and EQ VAS scores (2008)Swedish experience-based value sets for EQ-5D health states (2013)
this work references cited by second hop

References

  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement83,813 cited
  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.44,857 cited
  • 1990EuroQol - a new facility for the measurement of health-related quality of life15,736 cited
  • 2011Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)9,783 cited
  • 1996EuroQol: the current state of play5,812 cited
  • 2012Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets2,153 cited
  • 2012Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study1,580 cited
  • 2010Development of the EQ-5D-Y: a child-friendly version of the EQ-5D871 cited
  • 2010Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study465 cited
  • 2003A single European currency for EQ-5D health states459 cited
  • 2010A review of health utilities using the EQ-5D in studies of cardiovascular disease420 cited
  • 2014The minimum clinically important difference for EQ-5D index: a critical review343 cited
  • 2007Health Utilities Using the EQ-5D in Studies of Cancer285 cited
  • 2014Validity of EQ-5D-5L in stroke254 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2015Can The EQ-5D Detect Meaningful Change? A Systematic Review249 cited
  • 1997Guidelines for Pharmacoeconomic Studies233 cited
  • Cited by

    • 2020Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary115 cited
    • 2020An EQ-5D-5L Value Set for Vietnam113 cited
    • 2019Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe103 cited
    • 2019Valuing Health State: An EQ-5D-5L Value Set for Ethiopians98 cited
    • 2017Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients75 cited
    • 2018Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease65 cited